Harnessing Normal and Engineered Mesenchymal Stem Cells Derived Exosomes for Cancer Therapy: Opportunity and Challenges

There remains a vital necessity for new therapeutic approaches to combat metastatic cancers, which cause globally over 8 million deaths per year. Mesenchymal stem cells (MSCs) display aptitude as new therapeutic choices for cancer treatment. Exosomes, the most important mediator of MSCs, regulate tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmadi, Mahdi, Mahmoodi, Monireh, Shoaran, Maryam, Nazari-Khanamiri, Fereshteh, Rezaie, Jafar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699149/
https://www.ncbi.nlm.nih.gov/pubmed/36430452
http://dx.doi.org/10.3390/ijms232213974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9699149/
https://www.ncbi.nlm.nih.gov/pubmed/36430452
http://dx.doi.org/10.3390/ijms232213974

Ejemplares similares